Galen Robotics completes $15 million first close of Series A
Galen Robotics completed a $15 million first close of an oversubscribed Series A to bring its collaborative soft-tissue surgical robot to market.
Evidence notes
- Ambix Healthcare Partners led the financing.
- The company had submitted its robot to the FDA for consideration.
- Galen planned a service-led commercial model.
Company context
Galen Robotics develops a collaborative surgical robot designed to stabilise and position instruments during delicate soft-tissue procedures. The company pairs the platform with a service-led commercial model intended to reduce hospital capital expenditure and broaden access to robotic assistance.